AzTrials
AzTrials

Infected Extraction SocketsNCT07753044

Photoactivated Disinfection Versus Laser Disinfection of Infected Sockets on the Success of Immediate Implant Placement

A study testing Photoactivated disinfection, Er,Cr:YSGG laser disinfection and Chlorohexidine disinfection in people with Infected Extraction Sockets, run by Alexandria University at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Background: Dental implantology offers reliable tooth replacement options, but infections in extraction sockets can compromise osseointegration. Conventional disinfection methods, such as chlorhexidine, often fail to completely eliminate pathogenic microorganisms and may impair tissue healing. Read more about this study

Who is it for?
Ages 20 to 60 years
Conditions the study is for
Infected Extraction Sockets
What is being tested?
Photoactivated disinfection, Er,Cr:YSGG laser disinfection and Chlorohexidine disinfection
Could I receive a placebo?
No, everyone receives an active treatment
How many people
9 participants
Where
1 siteEgypt
Study dates
10 Jun 2025to 3 Feb 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 60 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Patients having posterior tooth/teeth indicated for extraction
  • Patients must exhibit radiographic evidence of infection, defined as chronic periapical pathology (radiolucency)
  • The extraction site should have intact surrounding alveolar bone
  • There must be at least 2 mm of sound bone beyond the root apex
  • Patients must be in overall good health and free from uncontrolled systemic conditions

Who cannot join

  • History of radiation therapy in the head and neck region
  • Pregnant or lactating women
  • Patients on long-term antibiotic therapy, as it could influence the outcomes
  • Heavy Smoking: More than 10-15 cigarettes per day.
  • Significant bruxism or parafunctional habits affecting implant stability.

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Outpatient Clinic of Oral and Maxillofacial Surgery Department, Faculty of Dentistry, Alexandria University, Egypt

    Alexandria, Azarita, 00203

Other trials in Egypt

About this study

Official title: Effect of Photoactivated Disinfection Versus Laser Disinfection of Infected Sockets on the Success of Immediate Implant Placement (a Randomized Controlled Clinical Trial)

Background: Dental implantology offers reliable tooth replacement options, but infections in extraction sockets can compromise osseointegration. Conventional disinfection methods, such as chlorhexidine, often fail to completely eliminate pathogenic microorganisms and may impair tissue healing. Photoactivated disinfection (PAD) and laser disinfection have emerged as promising alternatives. PAD employs a light-activated photosensitizer to generate reactive oxygen species (ROS), effectively disrupting bacterial membranes while preserving host cell viability. In parallel, laser disinfection utilizes focused light energy to eliminate bacterial biofilms and contaminated tissue with minimal thermal damage. In this study, we specifically utilize the Er,Cr:YSGG laser, which operates at a water-absorbing wavelength to induce micro-explosions that mechanically disrupt biofilms and promote a cleaner socket environment for improved osseointegration. Aim of the study: To compare the effectiveness of photoactivated disinfection (PAD), Er,Cr:YSGG laser disinfection, and conventional disinfection with chlorhexidine in decontaminating infected extraction sockets prior to immediate implant placement, promoting bone healing, and improving the osseointegration and stability of immediate implants placed in infected extraction sockets.

Being tested
Photoactivated disinfection, Er,Cr:YSGG laser disinfection, Chlorohexidine disinfection

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Photoactivated disinfectionOther

    Standard treatment + Toluidine blue + Light activation + Immediate implant placement

  • Er,Cr:YSGG laser disinfectionOther

    Standard treatment + Er,Cr:YSGG laser application + Immediate Implant placement

  • Chlorohexidine disinfectionOther

    Standard treatment + Chlorohexidine Irrigation + Immediate Implant placement

Study groups in NCT07753044
Study groupRoleWhat they receive
PADExperimentalNot described
Receives: Other: Photoactivated disinfection
Er,Cr:YSGG laser GroupExperimentalNot described
Receives: Other: Er,Cr:YSGG laser disinfection
Conventional groupActive comparatorNot described
Receives: Other: Chlorohexidine disinfection

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. implant stability

    Resonance Frequency Analysis (RFA) using Osstell ISQ: Implant Stability Quotient (ISQ) values will be recorded at 6 months after implant placement. Values from 1 to 100, the higher the ISQ, the higher the stability of the implant.

    Measured: 6 months

  2. change in bone density

    Bone density assessment using radiographs immediately post-operative and at 6 months.

    Measured: baseline and 6 months

  3. change in marginal bone loss

    Marginal Bone Loss (MBL) assessment using radiographs immediately postoperative and at 6 months.

    Measured: baseline and 6 months

Secondary outcomes (2)
  1. change in pain scores

    Post-operative pain will be assessed through a 10-point visual analogue scale (VAS). (0-1 = No pain, 2-4 = mild pain, 5-7 = moderate pain, 8-10 = severe pain).

    Measured: up to 7 days

  2. change in post-operative edema

    Post-operative edema will be assessed as follows None (no swelling), Mild (intra oral swelling confined to surgical field), Moderate (extra oral swelling in the surgical zone), Severe (extra oral swelling spreading beyond the surgical zone)

    Measured: up to 7 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Aug 2026
  2. Study start10 Jun 2025
  3. Primary completion3 Feb 2026
  4. Study completion3 Feb 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
9 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07753044
Sponsor's protocol ID
1044-03/2025
Status last verified
Aug 2026
First submitted
4 Aug 2026
Last updated
7 Aug 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Photoactivated disinfection, Er,Cr:YSGG laser disinfection and Chlorohexidine disinfection in people with Infected Extraction Sockets, run by Alexandria University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 7 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

implant stability (time frame: 6 months). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Aug 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in